MRC Holland supplies MLPA reagents to Manchester University NHS trust
- Manchester University NHS Foundation Trust
- North West
- Direct award
- 23 November 2026 to 22 November 2028
Manchester University NHS Foundation Trust is buying MLPA reagents from MRC Holland for the Northwest GLH.
MLPA is a laboratory method for spotting changes in the number of DNA copies and in methylation patterns linked to disease. MRC Holland invented the technique and makes the reagents it uses. The instruments needed to run them are already in the department, so the trust needs only the reagents.
As MRC Holland is the only firm with the rights to the reagents, the trust awarded it the £669,612 contract directly in October 2026. It will run to November 2028.
Contract ends November 2028
- What
- PCR and molecular diagnostic platforms
- Supplier
- MRC Holland
- Value
- £669,612
- How it was bought
- Direct award
- Dates and next
- Nov 2026 to Nov 2028